abrdn Life Sciences Investors
HQL
52 hedge funds and large institutions have $57.9M invested in abrdn Life Sciences Investors in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
13% more capital invested
Capital invested by funds: $51.1M → $57.9M (+$6.76M)
11% more funds holding
Funds holding: 47 → 52 (+5)
1.13% more ownership
Funds ownership: 11.58% → 12.71% (+1.1%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$1.44M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$1.19M |
| 3 |
Morgan Stanley
New York
|
+$1.01M |
| 4 |
LPL Financial
San Diego,
California
|
+$673K |
| 5 |
Cohen & Steers
New York
|
+$614K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$1.35M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$111K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$69.9K |
| 4 |
NIM
Needham Investment Management
New York
|
-$53.1K |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TJHA
51
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
| $1K | +$21 | +1 | +1% |
|
|
52
Bank of Nova Scotia
Toronto,
Ontario, Canada
| – | -$1.35M | -64,915 | Closed |
|
|
TWA
53
TCI Wealth Advisors
Tucson,
Arizona
| – | -$42K | -2,000 | Closed |
|
|
NFG
54
Next Financial Group
Houston,
Texas
| – | -$22K | -1,032 | Closed |
|
HQL Hedge Fund Activity: Q3 2017 in Review
52 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2017, worth a combined $57.9M — up 13% from $51.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new HQL positions and 4 closed out — a net gain of 5 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was Stephens Inc, opening a new position worth an estimated $1.44M. The largest seller was Bank of Nova Scotia, exiting entirely with an estimated $1.35M sold.
- 52 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2017, up from 47 in Q2 2017.
- Funds reported $57.9M of abrdn Life Sciences Investors stock for Q3 2017, up 13% quarter-over-quarter.
- 9 funds opened new abrdn Life Sciences Investors positions in Q3 2017 and 4 closed out, a net change of +5 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2017 was Stephens Inc, an estimated $1.44M added.
- The largest abrdn Life Sciences Investors seller in Q3 2017 was Bank of Nova Scotia, an estimated $1.35M sold.
Based on aggregated 13F filings for Q3 2017.